Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

AZZ CEO David Dingus Diagnosed With Pancreatic Cancer

RELATED NEWS
Trade AZZ now with 
3/4/2013 5:40 PM ET

AZZ Inc. (AZZ: Quote) said Monday that its President and Chief Executive Officer, David Dingus, has been recently diagnosed with cancer of the pancreas.

Dingus will begin an aggressive treatment commencing the week of March 4.

It is anticipated that during this period of treatment, all day-to-day operations will continue to be conducted by the organization currently in place, the company said and added that Dingus will continue in his role of Chief Executive Officer.

AZZ said Dingus and the senior management team will continue to work with the Board of Directors to continue to seek out all opportunities for profit enhancement, growth and expansion of the existing businesses and the successful implementation of the Aquilex SRO acquisition should the company receive the anticipated government approval to proceed.

Dingus may have a reduced work schedule during certain periods of his treatment, but he is not expected to be away for any extended periods of time, the company noted.

Click here to receive FREE breaking news email alerts for AZZ incorporated and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The Reserve Bank of New Zealand on Thursday raised its Official Cash Rate by 25 basis points, to 3.00 percent from 2.75 percent. The decision was in line with expectations, and it marks the second straight month with a rate hike following 24 straight meetings in which the rate was not changed. New Zealand's economic expansion has considerable momentum, with GDP estimated to have grown by 3.5 percent in the year to March. Apple Inc. said Wednesday after the markets closed that its second quarter profit rose 7% from last year, as sales surged and margins improved amid strong sales of its iPhones. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. At the same time, the company gave a slightly downbeat revenue forecast for the current quarter. Stocks moved mostly lower during trading on Wednesday, giving back some ground after trending higher over the past several sessions. Selling pressure was relatively subdued, however, limiting the downside for the markets. The major averages all closed in the red, although the tech-heavy Nasdaq underperformed its counterparts by a wide margin.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.